CD4 and HIV infectious disease: CCR5-specific ZFNs are capable of permanently inactivating the CCR5 gene in primary CD4 T cells, and ZFN-modification confers a survival advantage on gene-modified cells in the presence of CCR5-using HIV both in vitro and in a humanized mouse model of HIV infection [84].